Cargando…
Rapid drug increase and early onset of levodopa-induced dyskinesia in Parkinson’s disease
A higher levodopa dose is a strong risk factor for levodopa-induced dyskinesia (LID) in patients with Parkinson’s disease (PD). However, levodopa dose can change during long-term medication. We explored the relationship between levodopa dose and time to onset of LID using longitudinal multicenter da...
Autores principales: | Hong, Jin Yong, Sunwoo, Mun Kyung, Yoon, Jung Han, Kang, Suk Yun, Sohn, Young H., Lee, Phil Hyu, Kim, Seo Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7444533/ https://www.ncbi.nlm.nih.gov/pubmed/32817705 http://dx.doi.org/10.1371/journal.pone.0237472 |
Ejemplares similares
-
Cerebellar connectivity in Parkinson's disease with levodopa‐induced dyskinesia
por: Yoo, Han Soo, et al.
Publicado: (2019) -
White matter hyperintensities and risk of levodopa‐induced dyskinesia in Parkinson’s disease
por: Chung, Seok Jong, et al.
Publicado: (2020) -
Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson’s disease
por: Yoo, Han Soo, et al.
Publicado: (2022) -
Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018) -
Comparison of Endothelial Progenitor Cells in Parkinson's Disease Patients Treated with Levodopa and Levodopa/COMT Inhibitor
por: Lee, Phil Hyu, et al.
Publicado: (2011)